Jeremy Fox-Geen, the Chief Financial Officer of $CRCL, sold 23,830 shares of the company on 12-12-2025 for an estimated $2,144,700. We received data on the trade from a recent SEC filing. This was a sale of approximately 7.8% of their shares of this class of stock. Following this trade, they now own 282,173 shares of this class of $CRCL stock.
$CRCL Insider Trading Activity
$CRCL insiders have traded $CRCL stock on the open market 42 times in the past 6 months. Of those trades, 0 have been purchases and 42 have been sales.
Here’s a breakdown of recent trading of $CRCL stock by insiders over the last 6 months:
- JEREMY ALLAIRE (Chairman and CEO) has made 0 purchases and 6 sales selling 365,625 shares for an estimated $46,172,520.
- RAJEEV V DATE has made 0 purchases and 15 sales selling 530,446 shares for an estimated $44,606,677.
- PATRICK SEAN NEVILLE has made 0 purchases and 4 sales selling 328,943 shares for an estimated $39,092,069.
- NIKHIL CHANDHOK (Chief Product & Tech. Officer) has made 0 purchases and 6 sales selling 160,000 shares for an estimated $14,961,753.
- JEREMY FOX-GEEN (Chief Financial Officer) has made 0 purchases and 3 sales selling 73,830 shares for an estimated $8,309,405.
- HEATH TARBERT (President) has made 0 purchases and 2 sales selling 33,225 shares for an estimated $4,173,999.
- M MICHELE BURNS sold 29,946 shares for an estimated $3,805,387
- DANITA K OSTLING has made 0 purchases and 2 sales selling 3,952 shares for an estimated $389,371.
- TAMARA L SCHULZ (Chief Accounting Officer) has made 0 purchases and 2 sales selling 1,836 shares for an estimated $184,254.
- CRAIG W. BRODERICK sold 1,035 shares for an estimated $131,522
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CRCL Hedge Fund Activity
We have seen 231 institutional investors add shares of $CRCL stock to their portfolio, and 107 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 2,458,044 shares (+356.2%) to their portfolio in Q3 2025, for an estimated $325,887,473
- VANGUARD GROUP INC added 2,126,072 shares (+61.6%) to their portfolio in Q3 2025, for an estimated $281,874,625
- ATLAS MERCHANT CAPITAL LLC added 1,687,376 shares (+inf%) to their portfolio in Q3 2025, for an estimated $223,712,310
- GENERAL CATALYST GROUP MANAGEMENT, LLC removed 1,119,728 shares (-5.6%) from their portfolio in Q3 2025, for an estimated $148,453,538
- BLACKROCK, INC. added 1,082,068 shares (+31.5%) to their portfolio in Q3 2025, for an estimated $143,460,575
- SUMITOMO MITSUI TRUST GROUP, INC. added 959,309 shares (+282.1%) to their portfolio in Q3 2025, for an estimated $127,185,187
- FMR LLC removed 787,509 shares (-5.7%) from their portfolio in Q3 2025, for an estimated $104,407,943
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CRCL Revenue
$CRCL had revenues of $739.8M in Q3 2025. This is an increase of 65.95% from the same period in the prior year.
You can track CRCL financials on Quiver Quantitative's CRCL stock page.
$CRCL Congressional Stock Trading
Members of Congress have traded $CRCL stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CRCL stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN purchased up to $15,000 on 06/24.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CRCL Analyst Ratings
Wall Street analysts have issued reports on $CRCL in the last several months. We have seen 8 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 11/13/2025
- JP Morgan issued a "Overweight" rating on 11/13/2025
- Needham issued a "Buy" rating on 11/13/2025
- Monness, Crespi, Hardt issued a "Buy" rating on 11/10/2025
- William Blair issued a "Outperform" rating on 10/14/2025
- Canaccord Genuity issued a "Buy" rating on 09/11/2025
- Compass Point issued a "Sell" rating on 07/22/2025
To track analyst ratings and price targets for $CRCL, check out Quiver Quantitative's $CRCL forecast page.
$CRCL Price Targets
Multiple analysts have issued price targets for $CRCL recently. We have seen 14 analysts offer price targets for $CRCL in the last 6 months, with a median target of $129.0.
Here are some recent targets:
- Daniel Krebs from Wolfe Research set a target price of $60.0 on 12/02/2025
- James Yaro from Goldman Sachs set a target price of $80.0 on 11/21/2025
- David Koning from Baird set a target price of $110.0 on 11/14/2025
- Dan Dolev from Mizuho set a target price of $70.0 on 11/14/2025
- Brian Bedell from Deutsche Bank set a target price of $90.0 on 11/13/2025
- Jason Kupferberg from Wells Fargo set a target price of $128.0 on 11/13/2025
- John Todaro from Needham set a target price of $190.0 on 11/13/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
